The current stock price of AKAN is 1.5 USD. In the past month the price increased by 166.57%. In the past year, price decreased by -70.91%.
ChartMill assigns a technical rating of 5 / 10 to AKAN. When comparing the yearly performance of all stocks, AKAN is a bad performer in the overall market: 95.02% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to AKAN. AKAN has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months AKAN reported a non-GAAP Earnings per Share(EPS) of -12.28. The EPS increased by 99.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.76% | ||
| ROE | -95.78% | ||
| Debt/Equity | 0.08 |
Akanda Corp is a GB-based company operating in Pharmaceuticals industry. Akanda Corp. is a United Kingdom-based company, which is focused on the growth of its Canadian farming property in British Columbia. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
AKANDA CORP
1A, 1B Learoyd Road
New Romney GB
Employees: 5
Phone: 442034889514
Akanda Corp is a GB-based company operating in Pharmaceuticals industry. Akanda Corp. is a United Kingdom-based company, which is focused on the growth of its Canadian farming property in British Columbia. The firm plans to develop tetrahydrocannabinol (THC) and cannabidiol (CBD) facilities.
The current stock price of AKAN is 1.5 USD. The price increased by 11.11% in the last trading session.
AKAN does not pay a dividend.
AKAN has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
AKAN stock is listed on the Nasdaq exchange.
AKANDA CORP (AKAN) operates in the Health Care sector and the Pharmaceuticals industry.
AKANDA CORP (AKAN) currently has 5 employees.